The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma
Cancers · 01.04.2025 · 17 (7) · 1203
DOI: 10.3390/cancers17071203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 01.04.2025. Verfasst von John Rieth und 2 weiteren Autor:innen. Beteiligte Einrichtung: Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA 52242, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/Objectives: Despite conventional cytotoxic chemotherapy treatments, soft tissue sarcoma continues to remain a terminal diagnosis for most patients. Numerous chemotherapeutic agents have been trialed in soft tissue sarcoma, with marginal improvement in overall survival. Novel therapeutic approaches are needed to improve outcomes for this entity. Methods: the literature was reviewed, including a summary of pertinent adjuvant/neoadjuvant clinical trials and trials for metastatic disease.
Results
Chemotherapeutic agent use in adjuvant/neoadjuvant trials provided limited if any evidence of the benefit of chemotherapy in this space. Despite multiple trials in the metastatic space, novel chemotherapeutic agents appear to have limited long-term benefits for the management of soft tissue sarcoma. Suggestions for further research, particularly with neoadjuvant clinical trials, were made.
Conclusions
Chemotherapy remains an inadequate treatment option for soft tissue sarcoma, and novel therapies are needed. The neoadjuvant space provides an excellent opportunity to study the effects of innovative treatments in soft tissue sarcoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA 52242, USA.
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94158, USA.
ORCID-Profile: John Rieth, Varun Monga
Zitieren
APA
Rieth, J., Monga, V., & Milhem, M. (2025). The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma. Cancers, 17(7), 1203. https://doi.org/10.3390/cancers17071203
Vancouver
Rieth J, Monga V, Milhem M. The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma. Cancers. 2025;17(7):1203. doi:10.3390/cancers17071203
BibTeX
@article{Rieth2025,
author = {Rieth, John and Monga, Varun and Milhem, Mohammed},
title = {The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma},
journal = {Cancers},
year = {2025},
volume = {17},
number = {7},
pages = {1203},
doi = {10.3390/cancers17071203}
}
EUVIMED